Insider: Gano Kyle Chief Executive Officer - NEUROCRINE BIOSCIENCES INC
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 139,907 | 0 | 139,907 |
| Value | $19,711,497.23 | $0.00 | $19,711,497.23 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 02/13/2025 | DDS | 1,206 | Direct | COM | $116.86 | $140,933.88 | 139,907 |
| 02/13/2025 | DDS | 1,352 | Direct | COM | $116.84 | $157,974.17 | 138,872 |
| 02/10/2025 | DDS | 980 | Direct | COM | $118.39 | $116,020.34 | 137,658 |
| 01/31/2025 | DDS | 1,541 | Direct | COM | $152.87 | $235,577.45 | 136,778 |
| 01/15/2025 | DDS | 60,188 | Direct | COM | $141.50 | $8,516,656.17 | 135,392 |
| 01/15/2025 | DDS | 4,812 | Direct | COM | $141.50 | $680,893.67 | 135,392 |
| 02/13/2024 | DDS | 1,352 | Direct | COM | $132.89 | $179,673.63 | 135,166 |
| 02/08/2024 | DDS | 980 | Direct | COM | $134.20 | $131,519.14 | 133,952 |
| 02/06/2024 | DDS | 1,600 | Direct | COM | $142.20 | $227,522.08 | 133,072 |
| 01/31/2024 | DDS | 1,541 | Direct | COM | $140.70 | $216,812.54 | 131,635 |
| 08/21/2023 | DDS | 2,132 | Direct | COM | $107.41 | $228,992.79 | 130,250 |
| 02/08/2023 | DDS | 980 | Direct | COM | $103.99 | $101,910.00 | 128,096 |
| 02/07/2023 | DDS | 12,801 | Direct | COM | $102.41 | $1,310,968.33 | 127,216 |
| 02/07/2023 | DDS | 1,623 | Direct | COM | $102.29 | $166,014.07 | 115,719 |
| 02/06/2023 | DDS | 1,600 | Direct | COM | $105.64 | $169,027.52 | 114,257 |
| 01/31/2023 | DDS | 1,541 | Direct | COM | $109.98 | $169,486.42 | 112,820 |
| 02/08/2022 | DDS | 980 | Direct | COM | $79.67 | $78,078.56 | 111,173 |
| 02/07/2022 | DDS | 1,600 | Direct | COM | $80.77 | $129,224.96 | 110,294 |
| 02/07/2022 | DDS | 703 | Direct | COM | $80.68 | $56,720.15 | 105,619 |
| 02/07/2022 | DDS | 1,974 | Direct | COM | $80.80 | $159,499.59 | 107,395 |
| 02/07/2022 | DDS | 1,623 | Direct | COM | $80.78 | $131,104.48 | 108,857 |
| 01/05/2022 | DDS | 28,266 | Direct | COM | $85.50 | $2,416,751.48 | 104,984 |
| 02/08/2021 | DDS | 1,000 | Direct | COM | $116.83 | $116,825.90 | 103,306 |
| 02/08/2021 | DDS | 1,070 | Direct | COM | $116.89 | $125,070.37 | 102,406 |
| 02/08/2021 | DDS | 1,623 | Direct | COM | $116.83 | $189,621.58 | 104,768 |
| 1 2 3 Next Last You are at page 1 of 3 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2025 Zacks Investment Research